Clinical Conditions Associated With Cardiovascular Disease

LabCorp offers tests that can help diagnose and identify the underlying causes of conditions frequently associated with the development of cardiovascular disease (CVD), such as dyslipidemia, atherosclerosis, and familial hypercholesterolemia.

Test Name	Test N°	Comments
*National Heart, Lung, and Blood Institute. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive Summary. Bethesda, Md: National Heart, Lung, and Blood Institute, National Institutes of Health; 2001. NIH Publication 01-3670.
Dyslipidemia
Lipid Cascade	361946	Reflexes to lipoprotein analysis by nuclear magnetic resonance (NMR) when LDL-C is <130 mg/dL.
Lipid Panel *plus*	303756	Order Apolipoprotein B or NMR LipoProfile® indicated in addition to Lipid Panel.
Apolipoprotein B or	167015
NMR LipoProfile® Without Lipids (Without Graph)	884318
Secondary Dyslipidemia (Rule out common causes: diabetes, hypothyroidism, liver disease, renal disease*)
Alanine Aminotransferase (ALT/SGPT)	001545	Drugs such as progestins, anabolic steroids, and corticosteroids increase LDL cholesterol and decrease HDL cholesterol and are also causes of secondary dyslipidemia.*
Aspartate Aminotransferase (AST/SGOT)	001123
Glomerular Filtration Rate, Estimated (eGFR)	100768
Glucose, Plasma	001818
Hemoglobin (Hb) A_1c	001453
Microalbumin:Creatinine Ratio, Random Urine	140285
Renal Function Panel	322777
Thyroid-stimulating Hormone (TSH)	004259
Atherosclerosis / Inflammation
C-Reactive Protein (CRP), High Sensitivity (Cardiac Risk Assessment)	120766
Fibrinogen Activity	001610
Fibrinogen Antigen	117052
Homocyst(e)ine, Plasma	706994
Lipoprotein (a)	120188
Plasminogen Activator Inhibitor (PAI-1) Activity	146787
Sedimentation Rate, Modified Westergen	005215